← Leaderboards
Joel I Verter
George Washington University
$3,195,925
Attributed
$3,195,925
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$3,195,925 · 2
By mechanism
N01$3,195,925 · 2
Top collaborators
No co-investigators on record.
Most similar at George Washington University
Same institution · by research overlap
- Ionut Bebu$18,911,347
- Barbara Halina Braffett$22,111,472
- Sarah E. Fowler$55,133,840
- Gary L Simon$3,463,064
- Rebecca Gersnoviez Clifton$95,055,095
Others in their field
Top investigators on “Coronary Disorder”
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$57,671,528
- Joann Elisabeth Manson · Brigham And Women'S Hospital$42,016,172
- Katherine M Detre · University Of Pittsburgh At Pittsburgh$40,692,402
- Stacey Gabriel · Massachusetts Institute Of Technology$34,637,180
- Mark J Daly · Broad Institute, Inc.$34,637,180
- Anne Christine Gelijns · Icahn School Of Medicine At Mount Sinai$31,836,791
Research focus
Coronary DisorderClinical ResearchHuman SubjectHuman Therapy EvaluationCardiovascular Disorder ChemotherapyCardiovascular Disorder PreventionChemopreventionCombination ChemotherapyDisease /Disorder Proneness /RiskFemaleHormone TherapyHuman MortalityAce InhibitorsMyocardial InfarctionAngiographyAntioxidantsAtherosclerotic PlaqueBioimaging /Biomedical Imaging
Grant awards (4)
CLINICAL COORDINATING CENTER FOR THE ANGIOGRAPHIC TRIAL$0
N01 · FY2001 · HV
PREVENTION OF EVENTS WITH ACE INHIBITORS--CLINICAL TRIAL$3,096,000
N01 · FY2000 · HC
CLINICAL COORDINATING CENTER FOR THE ANGIOGRAPHIC TRIAL$99,925
N01 · FY2000 · HV
PREVENTION OF EVENTS WITH ACE INHIBITORS--CLINICAL TRIAL$0
N01 · FY2000 · HC